title: Dasatinib May Override F317L BCR-ABL Kinase Domain Mutation in Patients with Chronic Myeloid Leukemia.
authors.affiliation: Diyarbakır Training and Research Hospital, Department of Hematology, Diyarbakır, Turkey.
authors.forename: Ahmet Emre
authors.initials: AE
authors.lastname: Eşkazan
authors.affiliation: İstanbul University Cerrahpaşa Faculty of Medicine, Department of Internal Medicine, Division of Hematology, İstanbul, Turkey.
authors.forename: Teoman
authors.initials: T
authors.lastname: Soysal